Detalhe da pesquisa
1.
Community Practice Implementation of a Self-administered Version of PREMM1,2,6 to Assess Risk for Lynch Syndrome.
Clin Gastroenterol Hepatol
; 16(1): 49-58, 2018 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-28668538
2.
Homologous recombination deficiency (HRD) status predicts response to standard neoadjuvant chemotherapy in patients with triple-negative or BRCA1/2 mutation-associated breast cancer.
Breast Cancer Res Treat
; 168(3): 625-630, 2018 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-29275435
3.
Prevalence of germ-line mutations in cancer genes among pancreatic cancer patients with a positive family history.
Genet Med
; 20(1): 119-127, 2018 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28726808
4.
An independent validation of a gene expression signature to differentiate malignant melanoma from benign melanocytic nevi.
Cancer
; 123(4): 617-628, 2017 02 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-27768230
5.
Identification of a Variety of Mutations in Cancer Predisposition Genes in Patients With Suspected Lynch Syndrome.
Gastroenterology
; 149(3): 604-13.e20, 2015 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-25980754
6.
Targeted deletion of collagen V in tendons and ligaments results in a classic Ehlers-Danlos syndrome joint phenotype.
Am J Pathol
; 185(5): 1436-47, 2015 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-25797646
7.
Frequency of mutations in individuals with breast cancer referred for BRCA1 and BRCA2 testing using next-generation sequencing with a 25-gene panel.
Cancer
; 121(1): 25-33, 2015 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-25186627
8.
Incidence of BRCA1 and BRCA2 non-founder mutations in patients of Ashkenazi Jewish ancestry.
Breast Cancer Res Treat
; 149(1): 223-7, 2015 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-25476495
9.
Erratum to: Incidence of BRCA1 and BRCA2 non-founder mutations in patients of Ashkenazi Jewish ancestry.
Breast Cancer Res Treat
; 151(1): 233, 2015 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-25850536
10.
BRCA1, BRCA2, PALB2, and CDKN2A mutations in familial pancreatic cancer: a PACGENE study.
Genet Med
; 17(7): 569-77, 2015 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-25356972
11.
Lynch Syndrome Patients with Limited Family History Identified in a Laboratory Setting: A Descriptive Study.
Oncology
; 89(4): 221-6, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26393997
12.
Patients Tested at a Laboratory for Hereditary Cancer Syndromes Show an Overlap for Multiple Syndromes in Their Personal and Familial Cancer Histories.
Oncology
; 89(5): 288-93, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26315041
13.
Hereditary cancer-associated mutations in women diagnosed with two primary cancers: an opportunity to identify hereditary cancer syndromes after the first cancer diagnosis.
Oncology
; 88(4): 226-33, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-25503195
14.
Clinical validation of a gene expression signature that differentiates benign nevi from malignant melanoma.
J Cutan Pathol
; 42(4): 244-52, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25727210
15.
Functional evaluation of BRCA2 variants mapping to the PALB2-binding and C-terminal DNA-binding domains using a mouse ES cell-based assay.
Hum Mol Genet
; 21(18): 3993-4006, 2012 Sep 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-22678057
16.
Development and validation of a new algorithm for the reclassification of genetic variants identified in the BRCA1 and BRCA2 genes.
Breast Cancer Res Treat
; 147(1): 119-32, 2014 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-25085752
17.
Detection of PSMA expression on circulating tumor cells by blood-based liquid biopsy in prostate cancer.
J Circ Biomark
; 13: 1-6, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38415240
18.
Collagen V is a dominant regulator of collagen fibrillogenesis: dysfunctional regulation of structure and function in a corneal-stroma-specific Col5a1-null mouse model.
J Cell Sci
; 124(Pt 23): 4096-105, 2011 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-22159420
19.
PSMA-positive Circulating Tumor Cell Detection and Outcomes with Abiraterone or Enzalutamide Treatment in Men with Metastatic Castrate-resistant Prostate Cancer.
Clin Cancer Res
; 29(10): 1929-1937, 2023 05 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-36897758
20.
Analysis of BRCA2 Copy Number Loss and Genomic Instability in Circulating Tumor Cells from Patients with Metastatic Castration-resistant Prostate Cancer.
Eur Urol
; 83(2): 112-120, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36123219